Connection

Susan Dorman to Latent Tuberculosis

This is a "connection" page, showing publications Susan Dorman has written about Latent Tuberculosis.
Connection Strength

3.323
  1. Latent Tuberculosis Infection. Reply. N Engl J Med. 2022 03 31; 386(13):e33.
    View in: PubMed
    Score: 0.803
  2. Latent Tuberculosis Infection. N Engl J Med. 2021 12 09; 385(24):2271-2280.
    View in: PubMed
    Score: 0.786
  3. Interferon-? release assays and tuberculin skin testing for diagnosis of latent tuberculosis infection in healthcare workers in the United States. Am J Respir Crit Care Med. 2014 Jan 01; 189(1):77-87.
    View in: PubMed
    Score: 0.453
  4. QuantiFERON-TB gold in-tube implementation for latent tuberculosis diagnosis in a public health clinic: a cost-effectiveness analysis. BMC Infect Dis. 2012 Dec 19; 12:360.
    View in: PubMed
    Score: 0.422
  5. Programmatic impact of QuantiFERON-TB Gold In-Tube implementation on latent tuberculosis diagnosis and treatment in a public health clinic. PLoS One. 2012; 7(5):e36551.
    View in: PubMed
    Score: 0.404
  6. Rifapentine Population Pharmacokinetics and Dosing Recommendations for Latent Tuberculosis Infection. Am J Respir Crit Care Med. 2020 09 15; 202(6):866-877.
    View in: PubMed
    Score: 0.180
  7. Comparing TSPOT assay results between an Elispot reader and manual counts. Tuberculosis (Edinb). 2016 12; 101S:S92-S98.
    View in: PubMed
    Score: 0.137
  8. Differential positive TSPOT assay responses to ESAT-6 and CFP-10 in health care workers. Tuberculosis (Edinb). 2016 12; 101S:S83-S91.
    View in: PubMed
    Score: 0.137
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.